⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

IONS

Ionis Pharmaceuticals, Inc.

Healthcare · Biotechnology

56.02USD

-0.6900 (-1.22%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 56.02
P/E—
Dvd Ind Yld—
P/B21.43
P/S10.8
Curr EV/T12M EBITDA-16.8
Mkt Cap (USD)9.4B
Curr EV (USD)9.7B
2)

Per Share Data

EPS T12M-3.46
DPS—
Bk Val Per Sh2.66
Rev/Sh5.28
Cash/Sh12.65
Curr Shares Out166.2M
FCF/Sh-3.39
3)

Cash Flow Analysis

P/CF-19.0
Curr P/FCF-16.8
CF/NI0.9
Dvd P/O0.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales-56.8%
Eff Interest Rate1.1%
4)

Growth Potential

Dil EPS 1Y Gr21.7%
Cap 1Y Gr25.6%
BPS 1Y Gr-22.3%
R&D To Sales20.2%
Retention Rate100.0%
Rev 1Y Gr33.8%
FCF 1Y Gr41.4%
Assets 1Y Gr17.3%
5)

Profitability

EBITDA-0.6B
EBIT-0.6B
Operating Margin-68.0%
Pretax Margin-64.3%
Net Margin-64.7%
ROA-18.9%
ROE-105.5%
ROC—
Asset Turnover0.29
6)

Structure

Current Ratio7.89
Quick Ratio6.85
Debt/Assets58.8%
Debt/Com Eq400.3%
Net Debt/EBITDA-2.42
Tot Debt/Capital80.0%
Gross Margin98.2%
EBIT/Int Exp-31.6

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.